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Edited by Varda RotterAbstract Sumoylation is an important post-translational modi-
ﬁcation, which is also involved in the pathogenesis of many neu-
rodegenerative diseases. We previously reported that DJ-1
decreases Bcl-2 associated X protein expression through repress-
ing p53 transcriptional activity. Here we show that DJ-
1(K130R), the non-sumoylatable mutant form of DJ-1, shifts
from nucleus to cytoplasm, fails to repress p53 transcriptional
activity and loses its protective function against ultraviolet in-
duced cell death. Our ﬁndings suggest that sumoylation is critical
for DJ-1 to repress p53 transcriptional activity.
 2008 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Parkinsons disease (PD) is a common neurodegenerative dis-
order due to the progressive loss of dopaminergic neurons in
the substantia nigra pars compacta (SNc). Although most cases
of PD are sporadic, studies on the rare familial forms of PD
have yielded crucial insights into this disease [1]. Recently, loss
of DJ-1 function caused by the mutations in DJ-1 gene has been
found to be linked with autosomal recessive early onset PD [2].
Increasing studies reveal that DJ-1 has multiple roles in various
biological processes related to the possible etiology of PD [3–7].
Sumoylation has emerged as an important post-translational
modiﬁcation that regulates the properties and functions of
many proteins. In neurodegenerative diseases, sumoylation
has been conﬁrmed to contribute to the pathogenesis of familial
amyotrophic lateral sclerosis (FALS), Huntington disease and
Alzheimers disease [8–10]. DJ-1 was found to be sumoylated
on K130 site, which is necessary for DJ-1 to exert its full activ-
ities [7]. However, how the sumoylation modiﬁcation aﬀects theAbbreviations: PD, Parkinsons disease; SNc, substantia nigra pars
compacta; Bax, Bcl-2 associated X protein; EGFP, enhanced green
ﬂuorescent protein; PBS, phosphate buﬀer solution; DMEM, Dul-
beccos modiﬁed Eagles medium; Erk1, extracellular signal-regulated
kinases 1; ANOVA, analysis of variance; HRP, horseradish peroxi-
dase; FITC, ﬂuorescein isothiocyanate; PI, propidium iodide; UV,
ultraviolet
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doi:10.1016/j.febslet.2008.03.003activities of DJ-1 keeps largely unknown. Recently, we reported
that DJ-1 decreases Bcl-2 associated X protein (Bax) through
repressing p53 transcriptional activity, which is consistent with
the observation in zebraﬁsh model [11]. In this study, we further
showed that a sumoylation-deﬁcient mutant of DJ-1, DJ-
1(K130R), shifts from nucleus to cytoplasm, fails to repress
p53 transcriptional activity on Bax promoter and loses its activ-
ity in anti-apoptosis.2. Materials and methods
2.1. Plasmid constructs
The human DJ-1 cDNA was ﬁrst ampliﬁed by RT-PCR using total
RNA extracted from 293 cells with primers 5 0-CGGGATCCC-
CATGGCTTCCAAAAGAAG-3 0 and 5 0-CGCTCGAGCTGCTG-
GA- GTCTTTAAGAAC-3 0. pEGFP-N1-DJ-1 was generated by
inserting the PCR product into pEGFP-N1 at BglII/SalI sites. For cre-
ating construct expressing FLAG-DJ-1, we subcloned the PCR prod-
uct, ampliﬁed with primers 5 0-CCCTCGAGATGGCTTCCAAAA-
GAGC-3 0 and 5 0-CGGGATCCGCTGCTCTAGTCTTTAAG-30, into
p3·Flag-myc-CMV vector (Sigma). DJ-1(K130R) was generated with
primers 5 0-CCCTCTTGCTAGAGACAAAATG-3 0 and 5 0-TGTGTT-
GTAACTTTACTTCC-3 0 to convert lysine 130 to arginine.
Full length human p53 cDNA was ﬁrst obtained by PCR from a
human fetal brain cDNA library (Clonetech) with primers 5 0-CCGCT-
CGAGATGGAGGAGCCGCAGTC-3 0 and 5 0-CGCGGATCCTCA-
GTCTGAGTCAGG-3 0, and then inserted into p3·Flag-myc-CMV
vector (Sigma).
2.2. Cell culture, transfection and apoptosis assay
Murine neuroblastoma cell line Neuro2A cells, human dopaminergic
neuroblastoma cell line SH-SY5Y cells or human embryonic kidney
293 cells were cultured in Dulbeccos modiﬁed Eagles medium
(DMEM) (GIBCO) containing 10% calf serum (GIBCO), while the
p53 negative human lung carcinoma cell line H1299 cells were main-
tained in RPMI medium 1640 (GIBCO) supplemented with 10% fetal
bovine serum (Hyclone). Cells were transfected with expressing vectors
using Lipofectamine 2000 reagent (Invitrogen) according to the manu-
facturers instructions. Forty-eight hours after transfection, cells were
exposed to ultraviolet (UV)-B and apoptosis were assessed by using
FACSCalibur ﬂow cytometer (Becton Dickinson) according to the
manufactures instructions (Biosea, Beijing, China). Brieﬂy, cells were
collected by centrifugation in a refrigerated microcentrifuge and resus-
pended with 200 ll Binding Buﬀer. After the addition of 10 ll Annexin
V-ﬂuorescein isothiocyanate (FITC) and 5 ll propidium iodide (PI),
cells were kept in dark at room temperature for 15 min. Then the cells
were added for another 300 ll Binding Buﬀer and assessed within 1 h.
Data analysis was performed with CellQuest software.
2.3. Immunoblot analysis
Proteins were separated by 12% SDS–PAGE, followed by transfer-
ring onto polyvinylidene diﬂuoride membrane (Millipore). The follow-
ing primary antibodies were used. Monoclonal anti-Bax antibody and
anti-GFP antibody were from Santa Cruz Biotech. Monoclonalation of European Biochemical Societies.
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Fig. 1. DJ-1, but not DJ-1(K130R), localizes to nucleus. (A and B) Endogenous DJ-1 localizes to nucleus in SH-SY5Y or Neuro2A cells. SH-SY5Y
(A) or Neuro2A (B) cells were subjected to immunocytochemistry using anti-DJ-1 antibodies and FITC-conjugated anti-rabbit IgG. The DJ-1
immunoﬂuorescence is green (a) and the nuclei, stained with DAPI, are blue (b). The merged picture (c) and phase observation of this ﬁeld (d) are also
provided. Bar: 10 lm. (C and D) Mutation of DJ-1 sumoylation site causes its translocation from nucleus to cytoplasm. H1299 cells (C) or 293 cells
(D) were transfected with EGFP (a–c), DJ-1-EGFP (d–f) or DJ-1(K130R)-EGFP (g–i) and the nuclei were stained blue with Hoechst 33342 (b,e,h).
The merged pictures reveal that overexpressed EGFP or DJ-1-EGFP distributes diﬀusively both in nucleus and cytoplasm (c and f). But DJ-
1(K130R)-EGFP, a non-sumoylatable mutant, shows predominantly cytoplasmic localization (i). Bar: 10 lm. (E) Subcellular fractionation of cells
expressing EGFP, DJ-1-EGFP or DJ-1(K130R)-EGFP. Two hundred and ninety-three cells expressing EGFP, DJ-1-EGFP or DJ-1(K130R)-EGFP
were fractionated into cytoplasmic (C) and nuclear fractions (N), followed by immunoblot analysis using anti-GFP antibody, anti-GAPDH antibody
or anti-Max antibodies. GAPDH and Max were used here as speciﬁc cytoplasmic and nuclear markers, as well as loading controls. (F) Quantitative
data from E are shown. Band density of EGFP, DJ-1-EGFP and DJ-1(K130R)-EGFP relative to that of GAPDH or Max was analyzed by one way
analysis of variance (ANOVA) with post hoc Tukeys test. Data are shown as mean ± S.E. values from three independent transfection experiments. *,
P < 0.05 indicates statistically signiﬁcant diﬀerence in band density of cytoplasmic (C) vs. that of nuclear (N) fraction from cells transfected with DJ-
1(K130R)-EGFP. WT, wild-type.
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Fig. 1 (continued)
J. Fan et al. / FEBS Letters 582 (2008) 1151–1156 1153anti-GAPDH antibody was from Chemicon. Polyclonal anti-Max anti-
bodies, anti-extracellular signal-regulated kinases 1 (Erk1) antibodies
and anti-caspase-3 antibodies were from Santa Cruz Biotech. The sec-
ondary antibodies, sheep anti-mouse IgG-horseradish peroxidase
(HRP) antibodies or anti-rabbit IgG-HRP antibodies were from
Amersham Pharmacia Biotech. The proteins were visualized using an
ECL detection kit (Amersham Pharmacia Biotech).
2.4. Immnunocytochemistry
SH-SY5Y cells grown in chamber slides were washed with phos-
phate buﬀer solution (PBS) and ﬁxed in PBS with 4% paraformalde-
hyde for 5 min and then treated with 0.25% Triton X-100 for10 min. After blocking with 4% BSA/PBS for 1 h, the cells were incu-
bated with anti-DJ-1 antibodies for 1 h at room temperature. Then, the
cells, after being washed with PBS, were incubated with FITC-conju-
gated donkey anti-rabbit antibodies (Santa Cruz Biotechnology) for
1 h followed by incubation with 4 0,6-diamidino-2-phenylindole (DAPI)
(Sigma) for 3 min. Finally, the cells were observed using an inverted
system microscope IX71 (Olympus).
2.5. Subcellular fractionation
Cells transfected with expression plasmids were fractionated into
cytoplasmic and nuclear fractions 24 h after transfection. After being
washed twice with pre-cold PBS, cells were lysed in Fractionation
1154 J. Fan et al. / FEBS Letters 582 (2008) 1151–1156Buﬀer containing 10 mM Tris–HCl, pH 7.5, 1 mM EDTA, 0.5%
NP-40 and complete mini protease inhibitor cocktail for 30 min at
4 C. Following the centrifugation at 600 · g for 10 min at 4 C, the
supernatant were collected as cytoplasmic fraction. The pellets, resus-
pended with Pellet Buﬀer containing 2% SDS, as nuclear fraction.
2.6. Luciferase reporter gene assay
H1299 cells were cotransfected with pGL3-Bax Luciferase construct
and/or a ﬁxed amount of FLAG-p53, along with FLAG, FLAG-DJ-1
or FLAG-DJ-1(K130R), respectively. Renilla expressing plasmid pRL-
CMV was cotransfected to normalize the variations in transfection eﬃ-
ciency. Both ﬁreﬂy and Renilla activities were measured with Dual
Luciferase Reporter Systems using Veritas Microplate luminometer
according to the manufactures instructions.3. Results
3.1. Mutation of DJ-1 sumoylation site results in its
translocation from nucleus to cytoplasm
To investigate the subcellular localization of DJ-1 in our cel-
lular model, we performed the immunoﬂuorescent staining in
SH-SY5Y cells, a dopaminergic neuroblastoma cell line. As
shown in Fig. 1A, endogenous DJ-1 mainly localizes in nucleus
(Fig. 1A).Similar results were obtained in Neuro2A cells
(Fig. 1B). It is reported that K130 is the only sumoylation site
for DJ-1 [7]. Studies indicate that nuclear targeting of many
cytoplasmic proteins is required for sumoylation. To examine
whether sumoylation of DJ-1 aﬀects its localization and bio-
logical functions, we generated a mutant form of DJ-1, DJ-
1(K130R), in which lysine 130 is converted to arginine. We
transfected H1299 cells with enhanced green ﬂuorescent pro-
tein (EGFP), DJ-1-EGFP or DJ-1(K130R)-EGFP. Overex-
pressed DJ-1-EGFP shows a diﬀusive distribution both in
nucleus and cytoplasm (Fig. 1C). Interestingly, DJ-
1(K130R)-EGFP, a non-sumoylatable mutant, is predomi-
nantly cytoplasmic (Fig. 1C). Same results were obtained using
293 cells (Fig. 1D), indicating that the eﬀects of SUMO mod-
iﬁcation on DJ-1 localization may be a common phenomenon,
independent of cell types. To further conﬁrm these ﬁndings, we
transfected 293 cells with EGFP or DJ-1-EGFP or DJ-
1(K130R)-EGFP and examined the levels of EGFP, DJ-1-
EGFP and DJ-1(K130R)-EGFP in the fractions of cytoplasm
or nucleus by immunoblot analysis using anti-GFP antibody.
As shown in Fig. 1E, the level of DJ-1(K130R)-EGFP is much
lower in the nuclear fraction than that in the cytoplasmic frac-
tion. However, the levels of EGFP or DJ-1-EGFP are similar
in both fractions. Quantitative data are shown in Fig. 1F.
These results are consistent with our observations using ﬂuo-
rescent microscope (Fig. 1C and D).
3.2. DJ-1(K130R) loses its ability in anti-apoptosis
As the cellular localization of non-sumoylatable mutant DJ-
1 apparently diﬀers with wild-type DJ-1, we determined the
protective eﬀects of DJ-1(K130R) by ﬂow cytometry analysis
using annexin V and PI staining. Neuro2A cells transfected
with FLAG, FLAG-DJ-1 or FLAG-DJ-1(K130R) were ex-
posed to UV (20 mJ/cm2) two days after transfection. After
recovery for additional 14 h, cells were stained with annexin
V/PI, followed by ﬂow cytometry analysis. As shown in
Fig. 2A, relative high percentages of cell death are presented
in FLAG expressing Neuro2A cells (27.96% and 18.93%).
However, they decrease sharply to 8.72% and 6.93% in cellsexpressing FLAG-DJ-1. In contrast, the percentages reach
16.85% and 14.88% in cells transfected with FLAG-DJ-
1(K130R), indicating its limited role in rescuing cells from
death. To evaluate whether the sumoylation deﬁcient mutant
DJ-1 aﬀects its regulation for Bax, we transfected Neuro2A
cells with FLAG-DJ-1, FLAG-DJ-1(K130R) or FLAG alone.
The cells were harvested 48 h after transfection, followed by
immunoblot analysis using antibody to Bax. Cells expressing
FLAG-DJ-1 have lower protein level of endogenous Bax than
cells expressing FLAG alone. However, cells expressing
FLAG-DJ-1(K130R) does not change the level of Bax as com-
pared with cells expressing FLAG alone (Fig. 2B). Similar re-
sults were obtained when we transfected Neuro2A cells with
DJ-1-EGFP, DJ-1(K130R)-EGFP or EGFP alone (Fig. 2C).
Quantitative data for Fig. 2C are shown in Fig. 2D. Further-
more, DJ-1(K130R) mutant loses its ability to inhibit caspase
activation induced by UV stimulus (20 mJ/cm2) (Fig. 2E). Ta-
ken together, these data suggest that proper sumoylation of
DJ-1 is critical for its protection against cell death.
3.3. DJ-1, but not its K130R mutant, inhibits p53 transcriptional
activity on Bax promoter
In our previous study, we showed that the down-regulation
of Bax by DJ-1 is mediated by the inhibition of p53 transcrip-
tional activity [12]. To further determine whether the mutation
of DJ-1 sumoylation site has any eﬀect on its transcriptional
inhibitory activity, we performed the reporter gene assays. As
shown in Fig. 3A, expression of FLAG-p53 signiﬁcantly acti-
vates the transcription of the luciferase reporter gene. However,
wild-type DJ-1 greatly decreases FLAG-p53 transcriptional
activity. In contrast, DJ-1(K130R) has little eﬀect on p53 tran-
scriptional activity. These results support that the down-regula-
tion of Bax is mediated through the inhibition of p53
transcriptional activation to Bax promoter by DJ-1, but not
by DJ-1(K130R), the sumoylation-deﬁcient mutant (Fig. 3A).4. Discussion
Our previous data showed that DJ-1 decreases Bax expres-
sion through repressing p53 transcriptional activity and pro-
tects cell from apoptosis [12]. In our present study, we
further demonstrated that endogenous DJ-1 is nuclear in hu-
man dopaminegic neuroblastoma SH-SY5Y cells. However,
a non-sumoylatable mutant of DJ-1, DJ-1(K130R), is domi-
nantly cytoplasmic. Furthermore, DJ-1(K130R) loses its abil-
ity to repress p53 transcriptional activity on Bax promoter as
well as that to rescue cell death. Taken together, these data im-
ply that the proper sumoylation is required for DJ-1 to trans-
locate to nucleus where it interacts with p53 and repress p53
transcriptional activity. Several other proteins such as Ran-
GAP1 and CtBP have been reported that their subcellular
localization is mostly controlled by their sumoylation status.
Sumoylated RanGAP1 and CtBP are nuclear whereas unmod-
iﬁed ones are mainly cytoplasmic [13–15]. DJ-1, perhaps, is an-
other good example to illustrate this kind of translocation,
which depends much on the proper sumoylation. Sumoylation
has been considered as an important post-translational modi-
ﬁcation, contributing to the pathogenesis of neurodegenerative
diseases. The contribution of sumoylation to neurodegenera-
tion is either beneﬁcial or detrimental, according to speciﬁc
A C
D
B
E
Fig. 2. Sumoylation deﬁcient mutant K130R loses its protective eﬀects. (A) Neuro2A cells transfected with FLAG, FALG-DJ-1 or FLAG-DJ-
1(K130R) were exposed to UV (20 mJ/cm2) and recovered for another 14 h. Then the cells were stained with annexin V/PI, followed by ﬂow
cytometry analysis. Numbers within the upper or lower right quadrants represent the percentage of dead or apoptotic cells. (B and C) The whole
lysates from Neuro2A cells transfected with FLAG, FLAG-DJ-1, FLAG-DJ-1(K130R) (B) or EGFP, DJ-1-EGFP, DJ-1(K130R)-EGFP (C) were
subjected to immunoblot analysis using anti-Bax antibody. Anti-GAPDH antibody or anti-Erk1 antibodies serve as loading controls. (D) Band
density of Bax relative to that of Erk1 for (C) was analyzed by one way ANOVA with post hoc Tukeys test. Data are shown as mean ± S.E. values
from three independent transfection experiments. **, P < 0.01 vs. groups expressing EGFP or vs. groups expressing DJ-1(K130R)-EGFP. (E)
Neuro2A cells expressing EGFP, DJ-1-EGFP, DJ-1(K130R)-EGFP were treated with UV radiation (20 mJ/cm2) or not. The total cell lysates were
collected 14 h after UV exposure and subjected to immunoblot analysis using anti-caspase-3 antibodies and anti-Erk1 antibodies.
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tion of SOD1, whose mutations and accumulation are respon-
sible for the pathogenesis of FALS, increases SOD1 steady
state level and aggregation [8]. Huntingtin, a pathogenic pro-
tein of Huntington disease, can be modiﬁed either by SUMO
or by ubiquitin on overlapped lysine residues in a competitive
manner. Modiﬁcation by SUMO enhances huntingtin nucleartransport and toxicity, whereas modiﬁcation by ubiquitin re-
duces its toxicity [9]. The production of the neurotoxic amyloid
peptide, a pathogenic process in Alzheimers disease, is reduced
by SUMO2 polysumoylation in cultured cells [10]. Sumoyla-
tion also promotes the transport of proteins to degradation
sites such as nuclear bodies in neuronal intranuclear inclusion
disease [16]. Our data here showed that proper sumoylation is
AB
Fig. 3. DJ-1, but not its K130R mutant, inhibits p53 transcriptional
activity on Bax promoter. (A) H1299 cells were co-transfected with
pGL3-Bax Luciferase construct with or without a ﬁxed amount of
FLAG-p53, along with FLAG, FLAG-DJ-1, FLAG-DJ-1(K130R)
individually. Total amount of plasmid DNA was kept constant by the
addition of empty plasmid. Renilla expressing vector pRL-CMV was
used as a transfection internal control. Quantiﬁcation of luciferase
activities and calculations of relative ratios were performed. Data are
shown as mean ± S.E. values from three independent transfection
experiments. *, P < 0.05 indicates statistically signiﬁcant diﬀerence in
relative luciferase activities. (B) A hypothetical model illustrating the
role of DJ-1 in rescuing cell death through p53-Bax-caspase pathway.
DJ-1 may bind to p53 physically in the nucleus, decreases Bax
expression by attenuating p53 transcriptional activities, inhibits
subsequent caspase activation and ﬁnally rescues cell death. Whereas,
the non-sumoylatable K130R mutant of DJ-1, loses its cytoprotective
eﬀect due to the sequestration in cytoplasm.
1156 J. Fan et al. / FEBS Letters 582 (2008) 1151–1156required for DJ-1 nuclear localization, which is critical for DJ-
1 to repress p53 transcriptional activity, providing a clue to the
understanding of the signiﬁcance of sumoylation of DJ-1 and
its ability in gene transcriptional regulation.
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